SCHEMBL585970

SCHEMBL585970

O=C(O)CCCC(=O)OCC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAM P19021 3/20 0.63
TSHR P16473 4/20 0.56
SLC22A6 Q4U2R8 1/20 0.55
LMNA P02545 4/20 0.48
NFKB1 P19838 2/20 0.46
PMP22 Q01453 1/20 0.46
CAMK2A Q9UQM7 1/20 0.42
GABRR3 A8MPY1 1/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
HDAC3 O15379 1/20 0.40
GABBR2 O75899 1/20 0.40
CYP1A2 P05177 1/20 0.40
THRB P10828 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRR1 P24046 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRR2 P28476 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10578392 0.95 PAM (0.69) PAMTSHRSLC22A6LMNANFKB1
SCHEMBL1712357 0.93 PAM (0.73) PAMTSHRSLC22A6LMNANFKB1
SCHEMBL27730313 0.93 PAM (0.73) PAMTSHRSLC22A6LMNANFKB1
SCHEMBL1845834 0.90 PAM (0.75) PAMTSHRSLC22A6LMNANFKB1
SCHEMBL1845790 0.87 PAM (0.79) PAMTSHRSLC22A6LMNANFKB1
SCHEMBL27697262 0.87 PAM (0.79) PAMTSHRSLC22A6LMNANFKB1
SCHEMBL27714306 0.87 PAM (0.79) PAMTSHRSLC22A6LMNANFKB1
SCHEMBL11956805 0.85 PAM (0.69) PAMTSHRSLC22A6LMNANFKB1
SCHEMBL530330 0.84 PAM (0.56) PAMTSHRSLC22A6LMNANFKB1
SCHEMBL9558119 0.84 SLC22A6 (0.61) PAMTSHRSLC22A6LMNANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150283092-A1 DRUG DELIVERY COMPOSITION ALKERMES PHARMA IRELAND LTD (IE) 2015-10-08 US disclosed
EP-2416764-A1 DRUG DELIVERY COMPOSITION Alkermes Pharma Ireland Limited (IE) 2012-02-15 EP disclosed
EP-2416782-A1 CONTROLLED-RELEASE CLOZAPINE COMPOSITIONS Alkermes Pharma Ireland Limited (IE) 2012-02-15 EP disclosed
US-20100260858-A1 DRUG DELIVERY COMPOSITION ELAN PHARMA INTERNATIONAL LIMITED (IE) 2010-10-14 US disclosed
US-20100260859-A1 CONTROLLED-RELEASE CLOZAPINE COMPOSITIONS ELAN PHARMA INTERNATIONAL LIMITED (IE) 2010-10-14 US disclosed
WO-2010118232-A1 CONTROLLED-RELEASE CLOZAPINE COMPOSITIONS ELAN PHARMA INTERNATIONAL LIMITED (IE) 2010-10-14 WO disclosed
WO-2010118228-A1 DRUG DELIVERY COMPOSITION ELAN PHARMA INTERNATIONAL LIMITED (IE) 2010-10-14 WO disclosed
EP-1227800-A1 OSMOTIC CONTROLLED RELEASE DRUG DELIVERY DEVICE Merck & Co., Inc. (US) 2002-08-07 EP disclosed
WO-2001032149-A1 OSMOTIC CONTROLLED RELEASE DRUG DELIVERY DEVICE MERCK & CO., INC. (US) 2001-05-10 WO disclosed